David Kirn

David Kirn

Founder at 4D MOLECULAR THERAPEUTICS, INC.

Net worth: 39 M $ as of 2024-04-29

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. David H.
Kirn
, MD, is a Chief Executive Officer & Director at 4D Molecular Therapeutics, Inc., a Chief Executive Officer at ReIGNITE Therapeutics, Inc. and a Professor at University of Oxford.
He is on the Board of Directors at 4D Molecular Therapeutics, Inc. and Coagulant Therapeutics, Inc. Dr. Kirn was previously employed as a Chief Medical Officer by SillaJen Biotherapeutics, Inc., a Member by Harvard University, an Executive Chairman by Ignite Immunotherapy, Inc., a Principal by IP2IPO Innovations Ltd., an Advisor by National Institutes of Health, a Vice President-Clinical Research by Onyx Pharmaceuticals, Inc., a Faculty Member by Specialist Diabetes Research & Treatment Centre LLC, a Faculty Member by The University of California, San Francisco, and a Principal by Warner-Lambert Co. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from The University of California, San Francisco.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-02 1,659,513 ( 3.24% ) 39 M $ 2024-04-29

David Kirn active positions

CompaniesPositionStart
4D MOLECULAR THERAPEUTICS, INC. Founder 2013-09-11
University of Oxford Corporate Officer/Principal -
Director/Board Member -
All active positions of David Kirn

Former positions of David Kirn

CompaniesPositionEnd
Founder 2018-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
The University of California, San Francisco Corporate Officer/Principal -
See the detail of David Kirn's experience

Training of David Kirn

University of California, Berkeley Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kirn's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
4D MOLECULAR THERAPEUTICS, INC.

Health Technology

Private companies8

Health Technology

Health Technology

Commercial Services

Government

Commercial Services

Health Services

Health Technology

Health Technology

See company connections